Inorganic nanoparticles as carriers for efficient cellular delivery

By Z. Xu, Q. Zeng, G. Lu, Aibing Yu. 2006

936 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Materials Chemistry

View Paper: https://www.semanticscholar.org/paper/6e965676154f59ce3fc3dfc74758db9ef7a5c280

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

In Materials Chemistry

Citations in the corpus

A review on green synthesis of silver nanoparticles and their applications (2017, background): “Ag-NPs have a substantial surface zone which results into noteworthy biochemical reactivity, catalytic activity, and atomic behavior compared with bigger particles having same chemical composition (Xu et al. 2006).”
Nanoparticles for Cancer Therapy: Current Progress and Challenges (2021, background): ““Anti-HER2 functionalized gold-on-silica nanoshells” have been shown to aim HER2 positive breast cancer cells [104].”
Biosynthesis of biocompatible cadmium telluride quantum dots using yeast cells (2010, background): “7(b)), then gradually become embedded by deforming the membrane and endocytose into the cell (step II), are then released from the endosome into the cytoplasm by disruption of the endosomal membrane (step III) and finally enter the nucleus via a nuclear translocation (step IV) [35].”
Assessment of the Evolution of Cancer Treatment Therapies (2011, background): “Viral carriers, organic cationic compounds, recombinant proteins and inorganic nanoparticles are the four kinds of carriers currently being explored for gene delivery applications [99,100].”
Inorganic Nanoparticles in Cancer Therapy (2010, neutral): “Other nanoparticles include the use of metal oxides such as SiO2 with functionalized surfaces and Fe3O4 (magnetic nanoparticles) as a vector for targeted delivery of drugs and genes with reasonably low toxicity (187).”
Medicinal applications of fullerenes (2007, background): “There are four major groups of drug and gene carriers which are organic cationic compounds, viral carriers, recombinant proteins and inorganic nanoparticles (Azzam and Domb 2004; Xu et al 2005).”
Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review (2011, background): “Rapid clearance from the body and extracellular enzymatic degradation by plasma nucleases are the major reasons that make direct gene delivery an inefficient process [77,78].”